MicroRNAs in the Pathobiology and Therapy of Atherosclerosis

Overview

Journal Can J Cardiol

Publisher Elsevier

Specialty Cardiology & Vascular Diseases

Date 2017 Feb 25

PMID 28232017

Citations 75

Authors

Benoit Laffont

Katey J Rayner

Affiliations

Soon will be listed here.

Abstract

MicroRNAs are short noncoding RNAs, expressed in humans and involved in sequence-specific post-transcriptional regulation of gene expression. They have emerged as key players in a wide array of biological processes, and changes in their expression and/or function have been associated with plethora of human diseases. Atherosclerosis and its related clinical complications, such as myocardial infarction or stroke, represent the leading cause of death in the Western world. Accumulating experimental evidence has revealed a key role for microRNAs in regulating cellular and molecular processes related to atherosclerosis development, ranging from risk factors, to plaque initiation and progression, up to atherosclerotic plaque rupture. In this review, we focus on how microRNAs can influence atherosclerosis biology, as well as the potential clinical applications of microRNAs, which are being developed as targets as well as therapeutic agents for a growing industry hoping to harness the power of RNA-guided gene regulation to fight disease and infection.

Citing Articles

MiRNA-34a, miRNA-145, and miRNA-222 Expression, Matrix Metalloproteinases, TNF-α and VEGF in Patients with Different Phenotypes of Coronary Artery Disease.

Iusupova A, Pakhtusov N, Slepova O, Khabarova N, Privalova E, Bure I Int J Mol Sci. 2024; 25(23.

PMID: 39684689 PMC: 11641108. DOI: 10.3390/ijms252312978.

Relationship Between the Occurrence of Depression and (rs6877842, rs10719) and (rs11077) Single-Nucleotide Polymorphisms in the Polish Population: A Case-Control Study.

Kowalczyk M, Kowalczyk E, Talarowska M, Majsterek I, Skrzypek M, Poplawski T Int J Mol Sci. 2024; 25(22).

PMID: 39596271 PMC: 11594337. DOI: 10.3390/ijms252212204.

Investigation of miRNA-199a-5p Expression and its Clinical Association With LDL Cholesterol Levels in Atherosclerosis.

Barut Z, Akdeniz F, Avsar O, Cabbar A In Vivo. 2024; 38(6):2656-2664.

PMID: 39477400 PMC: 11535918. DOI: 10.21873/invivo.13742.

Exosomal miRNAs Differentiate Chronic Total Occlusion from Acute Myocardial Infarction.

Son J, Park J, Bang J, Kim D, Moon I, Kong M Int J Mol Sci. 2024; 25(18).

PMID: 39337705 PMC: 11432064. DOI: 10.3390/ijms251810223.

MicroRNA miR-188-5p enhances SUMO2/3 conjugation by targeting SENP3 and alleviates focal cerebral ischemia/reperfusion injury in rats.

Iran J Basic Med Sci. 2024; 27(10):1260-1267.

PMID: 39229582 PMC: 11366937. DOI: 10.22038/ijbms.2024.76165.16485.

References

Chen T, Li Z, Jing T, Zhu W, Ge J, Zheng X . MicroRNA-155 regulates lipid uptake, adhesion/chemokine marker secretion and SCG2 expression in oxLDL-stimulated dendritic cells/macrophages. Int J Cardiol. 2011; 147(3):446-7. DOI: 10.1016/j.ijcard.2010.10.133. View

Wei Y, Zhu M, Corbalan-Campos J, Heyll K, Weber C, Schober A . Regulation of Csf1r and Bcl6 in macrophages mediates the stage-specific effects of microRNA-155 on atherosclerosis. Arterioscler Thromb Vasc Biol. 2015; 35(4):796-803. DOI: 10.1161/ATVBAHA.114.304723. View

Vickers K, Palmisano B, Shoucri B, Shamburek R, Remaley A . MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 2011; 13(4):423-33. PMC: 3074610. DOI: 10.1038/ncb2210. View

Krol J, Loedige I, Filipowicz W . The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010; 11(9):597-610. DOI: 10.1038/nrg2843. View

Cerchia L, Esposito C, Camorani S, Rienzo A, Stasio L, Insabato L . Targeting Axl with an high-affinity inhibitory aptamer. Mol Ther. 2012; 20(12):2291-303. PMC: 3519989. DOI: 10.1038/mt.2012.163. View

Rayner K, Sheedy F, Esau C, Hussain F, Temel R, Parathath S . Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J Clin Invest. 2011; 121(7):2921-31. PMC: 3223840. DOI: 10.1172/JCI57275. View

Zhuang G, Meng C, Guo X, Cheruku P, Shi L, Xu H . A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation. Circulation. 2012; 125(23):2892-903. DOI: 10.1161/CIRCULATIONAHA.111.087817. View

Liao Y, Wang Y, Guo Y, Lin W, Chang M, Juo S . Let-7g improves multiple endothelial functions through targeting transforming growth factor-beta and SIRT-1 signaling. J Am Coll Cardiol. 2013; 63(16):1685-94. DOI: 10.1016/j.jacc.2013.09.069. View

Donners M, Wolfs I, Stoger L, van der Vorst E, Pottgens C, Heymans S . Hematopoietic miR155 deficiency enhances atherosclerosis and decreases plaque stability in hyperlipidemic mice. PLoS One. 2012; 7(4):e35877. PMC: 3338496. DOI: 10.1371/journal.pone.0035877. View

10.

Ma F, Xu S, Liu X, Zhang Q, Xu X, Liu M . The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ. Nat Immunol. 2011; 12(9):861-9. DOI: 10.1038/ni.2073. View

11.

Yang K, He Y, Wang X, Lu L, Chen Q, Liu J . MiR-146a inhibits oxidized low-density lipoprotein-induced lipid accumulation and inflammatory response via targeting toll-like receptor 4. FEBS Lett. 2011; 585(6):854-60. DOI: 10.1016/j.febslet.2011.02.009. View

12.

Cuhlmann S, van der Heiden K, Saliba D, Tremoleda J, Khalil M, Zakkar M . Disturbed blood flow induces RelA expression via c-Jun N-terminal kinase 1: a novel mode of NF-κB regulation that promotes arterial inflammation. Circ Res. 2011; 108(8):950-9. DOI: 10.1161/CIRCRESAHA.110.233841. View

13.

Rayner K, Suarez Y, Davalos A, Parathath S, Fitzgerald M, Tamehiro N . MiR-33 contributes to the regulation of cholesterol homeostasis. Science. 2010; 328(5985):1570-3. PMC: 3114628. DOI: 10.1126/science.1189862. View

14.

Nazari-Jahantigh M, Wei Y, Noels H, Akhtar S, Zhou Z, Koenen R . MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J Clin Invest. 2012; 122(11):4190-202. PMC: 3484435. DOI: 10.1172/JCI61716. View

15.

Yvan-Charvet L, Wang N, Tall A . Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscler Thromb Vasc Biol. 2009; 30(2):139-43. PMC: 2812788. DOI: 10.1161/ATVBAHA.108.179283. View

16.

Du F, Yu F, Wang Y, Hui Y, Carnevale K, Fu M . MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2014; 34(4):759-67. PMC: 4036084. DOI: 10.1161/ATVBAHA.113.302701. View

17.

Zeng L, Zampetaki A, Margariti A, Pepe A, Alam S, Martin D . Sustained activation of XBP1 splicing leads to endothelial apoptosis and atherosclerosis development in response to disturbed flow. Proc Natl Acad Sci U S A. 2009; 106(20):8326-31. PMC: 2676169. DOI: 10.1073/pnas.0903197106. View

18.

Karakas M, Schulte C, Appelbaum S, Ojeda F, Lackner K, Munzel T . Circulating microRNAs strongly predict cardiovascular death in patients with coronary artery disease-results from the large AtheroGene study. Eur Heart J. 2016; 38(7):516-523. DOI: 10.1093/eurheartj/ehw250. View

19.

Kawamata T, Seitz H, Tomari Y . Structural determinants of miRNAs for RISC loading and slicer-independent unwinding. Nat Struct Mol Biol. 2009; 16(9):953-60. DOI: 10.1038/nsmb.1630. View

20.

Feng J, Xing W, Xie L . Regulatory Roles of MicroRNAs in Diabetes. Int J Mol Sci. 2016; 17(10). PMC: 5085760. DOI: 10.3390/ijms17101729. View